Non ci sono recensioni
This book focuses on innovative treatment options for breast cancer, including surgery, radiotherapy, systemic therapy and of course immunotherapy that is changing outcomes in some aggressive breast cancer histotypes. Subsequent chapters also address the ongoing emerging research in the screening, diagnostics, and management of all subtypes of breast cancers. All current landscapes and future perspectives in each molecular subtype: luminal, HER2-positive, and triple-negative breast cancers are discussed within the different chapters.
Breast cancer is still the most common cancer and cause of cancer deaths among women worldwide. The improvement of breast cancer outcome appears to be strictly related to the validation of precise biomarkers that enable us to better select personalized approaches in breast cancer management.
The closing chapters deal with the challenges of conducting research in the era of precision medicine for cancer. The book is edited and authored by leading experts in this field and will be of interest for clinicians and scientists alike.
Pages i-viii
Pages 1-27
Pages 29-62
Pages 63-88
Pages 89-104
Pages 105-147
Pages 149-174
Pages 175-198
Pages 199-218
Pages 219-235
Pages 237-281
Pages 283-302
Pages 303-341
Pages 343-351
Pages 353-368
Sei sicuro di voler eseguire questa azione?